Lakeland Industries, Inc. Form 10-K Summary
Reporting period: Fiscal year ended January 31, 2023, including fourth-quarter results for the three months ended January 31, 2023. The filing was dated April 17, 2023. Lakeland manufactures and sells industrial and public-sector protective clothing and accessories through global sales channels and more than 1,600 distributors.
Business Context and Strategic Developments
- Products include disposable and chemical protective garments, firefighting apparel, gloves, high-visibility clothing, high-performance wear and woven garments.
- Operations span five manufacturing countries: China, Mexico, Vietnam, India and Argentina. Sales reach more than 50 foreign countries, and international external sales represented approximately 57% of FY23 revenue.
- On December 2, 2022, Lakeland acquired UK-based Eagle Technical Products Limited for approximately $10.5 million in cash, subject to adjustments and earnout payments. Eagle expands the fire-service portfolio and sales presence in Europe and the Middle East.
- Lakeland plans to open a manufacturing facility in Monterrey, Mexico, during FY24 and expects continued investment in ERP systems, manufacturing capacity and product development.
Financial Performance
| Metric | FY23 | FY22 | Change |
|---|---|---|---|
| Net sales | $112.8 million | $118.4 million | Down 4.7% |
| Gross profit | $45.8 million | $50.9 million | Down 10.0% |
| Gross margin | 40.6% | 43.0% | Down 240 bps |
| Operating profit | $5.5 million | $16.0 million | Down 65.5% |
| Operating margin | 4.9% | 13.6% | Down 870 bps |
| Net income | $1.9 million | $11.4 million | Down 83.5% |
| Diluted EPS | $0.24 | $1.41 | Down $1.17 |
| Net cash from operating activities | $(5.5) million | $12.8 million | Declined $18.2 million |
- Fourth-quarter FY23 sales were $29.0 million versus $26.8 million in Q4 FY22; net income was $0.6 million versus $0.5 million.
- Fire, high-performance wear and woven product sales increased by $8.7 million in aggregate, partly reflecting Eagle sales. Disposables declined by $12.0 million and chemical products declined by $2.3 million, primarily due to lower COVID-related demand and uneven industrial demand.
- U.S. sales increased 2.9% to $49.0 million. Asia declined 17.1% to $24.7 million, Europe declined 19.4% to $8.3 million, while Canada increased 11.0% to $9.1 million.
- Margin pressure reflected raw-material, labor, freight and inflationary costs; foreign-exchange effects; pricing pressure on non-strategic products; and inventory write-downs as freight rates declined.
- Operating expenses increased 15.6% to $40.3 million, including higher currency translation expense, Eagle acquisition costs, restructuring costs, outbound freight, Monterrey start-up costs and professional fees.
- Income tax expense was $3.6 million, producing a 65.7% effective tax rate. The rate included $2.0 million of withholding taxes associated with planned repatriation of Chinese earnings.
Cash Flow, Balance Sheet, Debt and Liquidity
- Cash and cash equivalents were $24.6 million at January 31, 2023, down from $52.7 million. Working capital was approximately $87.0 million.
- Cash used in operations was $5.5 million, primarily because inventories increased $9.7 million and accounts receivable increased $2.3 million.
- Cash used in investing was $14.8 million, including $9.7 million paid for Eagle net of cash acquired, $3.1 million invested in Bodytrak and $2.0 million of capital expenditures.
- Cash used in financing was $5.9 million, primarily due to $5.4 million of share repurchases and $0.8 million of shares withheld for employee taxes.
- Inventory was $58.2 million, compared with $47.7 million a year earlier, and included $4.7 million of excess and obsolete inventory adjustments.
- The company had no borrowings under its $25.0 million secured revolving credit facility at January 31, 2023 and was in compliance with its debt covenants. A UK facility had approximately $0.4 million outstanding.
- Management stated that cash, expected operating cash flow and available borrowing capacity should be sufficient for operating and investing requirements for at least the next twelve months.
- On February 1, 2023, the board declared Lakeland’s first quarterly cash dividend of $0.03 per share, paid February 22, 2023. FY23 share repurchases totaled 390,989 shares costing $5.4 million, leaving approximately $5.4 million authorized for future repurchases.
Material Changes, Outlook and Unusual Items
- Management expects FY24 capital expenditures of approximately $3.0 million, primarily for global ERP deployment, completion of the Monterrey facility and equipment replacement.
- The Eagle purchase price allocation remains preliminary. The acquisition included approximately $3.2 million of estimated contingent consideration tied to revenue targets for periods ending April 30, 2023 and April 30, 2024.
- Lakeland invested approximately $3.1 million in Bodytrak during FY23 and owned 22.5% of the company at year-end. Lakeland recognized a $0.4 million equity-method loss in FY23 and may incur additional losses.
- Russia represented approximately 2.4% of FY23 consolidated revenue and 1.9% of net income. Russian assets were approximately $3.5 million, including $1.3 million of cash; no impairment was recorded as of January 31, 2023.
- The company identified a material weakness in controls over foreign-subsidiary currency translation and remeasurement. Management and Deloitte concluded that internal control over financial reporting and disclosure controls were not effective as of January 31, 2023. The financial statement audit opinion remained unqualified, but Deloitte issued an adverse opinion on internal control over financial reporting.
- Management began remediation, including enhanced reconciliations, revised Argentina trial-balance procedures and improved review of currency impacts. Remediation was not complete as of the filing date, and Eagle was excluded from the FY23 internal-control assessment under SEC guidance for recently acquired businesses.
- Key continuing risks include international manufacturing and trade exposure, China-related geopolitical and regulatory risks, foreign-exchange volatility, inflation and freight costs, supply-chain disruptions, cybersecurity, changing product standards, competition, product liability and potential PFAS-related regulation or claims.
- The filing does not provide formal revenue or earnings guidance beyond the stated FY24 capital-expenditure estimate.
Most Important Facts for Investors to Verify
- Whether the foreign-currency internal-control material weakness is remediated and whether future filings report additional control deficiencies or restatements.
- Actual FY24 performance of Eagle, including revenue growth, integration costs, intangible-asset amortization and earnout obligations.
- Inventory turnover, excess and obsolete inventory levels, and the potential for additional write-downs.
- Recovery of operating cash flow and the effect of working-capital investment on liquidity.
- Execution, cost and timing of the Monterrey facility and global ERP rollout.
- Exposure to China, Russia, tariffs, sanctions, currency movements and supply-chain disruption.
- Potential financial effects of PFAS regulation, product-liability claims and other environmental contingencies.
- Future dividend and repurchase decisions relative to covenant requirements, acquisition spending and available cash.